An interventional study of OMNiBiOTiC® Panda and Placebo in Diaper Dermatitis, sponsored by University Maribor. Recruiting at 1 site in Slovenia. Open to participants aged 1 Month to 2 Years. Per ClinicalTrials.gov, last updated 2025-11-24.
Sponsored by University Maribor · Not applicable, Interventional, and Treatment
The goal of this randomized controlled clinical trial is to determine the effect of the probiotic OMNiBiOTiC® Panda in treating diaper dermatitis in children under the age of two years. The main question it aims to answer is:
Is the probiotic OMNiBiOTiC® Panda effective in reducing the duration of diaper dermatitis in children under the age of two years?
Researchers will compare the probiotic and placebo group to see if the duration of diaper dermatitis is significant among the two groups.
Participants will:
38 studies on the registry are indexed under Diaper Rash; 4 are open to participants now.
This study's planned enrollment of 42 is below the median of 92 across 28 interventional studies indexed under Diaper Rash.
Browse Diaper Rash studies →University Maribor is the lead sponsor of 11 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Multistrain Probiotic OMNiBiOTiC® Panda containing probiotics and sunflower oil
Dietary Supplement: OMNiBiOTiC® Panda
Placebo containing sunflower oil and maltodextrin
Other: Placebo
Multistrain Probiotic OMNiBiOTiC® Panda containing: Bifidobacterium bifidum W23 Bifidobacterium lactis W51 Bifidobacterium lactis W52 Lactococcus lactis W58 and sunflower oil
Placebo containing sunflower oil and maltodextrin
Duration of diaper dermatis
Comparison of the duration of diaper dermatitis in children younger than two years in both arms via daily the use of the diary.
Time frame: 3 weeks supplementation
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Maribor